28 results on '"O'Neil, Janet"'
Search Results
2. Apitegromab in Spinal Muscular Atrophy (SMA): An Analysis of Multiple Efficacy Endpoints in the TOPAZ Trial (P15-5.005)
3. Relationship of pharmacokinetics and pharmacodynamics to apitegromab efficacy in patients with later-onset spinal muscular atrophy (Types 2 and 3 SMA): Results from the TOPAZ study
4. Adjudicating mild cognitive impairment due to Alzheimer’s disease as a novel endpoint event in the TOMMORROW prevention clinical trial
5. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial
6. IMS2020 Microwave Application Sessions and Panels
7. O4-11-02: DEFINING COGNITION IN PRE-DEMENTIA CLINICAL TRIALS: BASELINE NEUROPSYCHOLOGICAL DATA FROM THE TOMMORROW STUDY
8. EMC Society Board of Directors meeting
9. EMC society board of directors meeting
10. Letter from the editor
11. EMC society board of directors meeting
12. Letter from the editor
13. Letter from the editor
14. Special 50th anniversary section
15. EMC society board of directors meeting
16. Chapter chatter
17. Letter from the editor
18. P2‐083: Progress in the tommorrow study: A pharmacogenetics supported clinical trial to delay onset of mild cognitive impairment due to Alzheimer's disease with low‐dose pioglitazone
19. Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis
20. EMC Society Board of Directors Meeting
21. P4‐073: A PHARMACOGENETICS‐SUPPORTED CLINICAL TRIAL TO DELAY ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE USING LOW‐DOSE PIOGLITAZONE: AN UPDATE ON THE TOMORROW STUDY
22. P2-392: CROSS-CULTURAL VALIDATION AND NORMATIVE STUDY OF A NEUROPSYCHOLOGICAL BATTERY USED IN THE DETERMINATION OF CLINICAL ENDPOINTS TO DELAY ONSET OF MCI
23. Wireless Industry Day: A Full-Day Seminar Sponsored by MTT-19 and the IEEE Seattle Section
24. IMS2013 Publications
25. Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa
26. Maintenance of Heartburn Relief After Step-Down From Twice-Daily Proton Pump Inhibitor to Once-Daily Dexlansoprazole Modified Release
27. S1074 Tak-390MR, a Proton Pump Inhibitor with a Novel Dual Delayed Release Formulation, Maintains Healing and Controls Heartburn in GERD Patients with Healed Erosive Esophagitis
28. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.